SEARCH MEDIA COVERAGE


To refine your search select a single option or a combination of options:

 
 

Media Coverage

Displaying Media Coverage item(s) associated with lawyer Michael Morin
 
6 results
    • Paparazzi lights
    • 02 February 2016
      Law360
      With recent victories in significant patent infringement cases, the practice is recognized by Law360 for the second consecutive year.
      share view
    • Pills
    • 15 January 2016
      Law360
      The Patent Trial and Appeal Board denied two requests by Amgen for reviews of two AbbVie patents covering the megablockbuster Humira, just months after Amgen had asked the FDA for permission to market a biosimilar version of the autoimmune disease drug.
      share view
    • 08 October 2015
      Law360
      Attorneys have only 15 minutes to argue their side of an intellectual property dispute before the Federal Circuit. Partner Michael Morin provides tips on how to make the most of this allotted time.
      share view
    • 08 April 2015
      The Litigation Daily
      Though hardly for lack of trying, the London-based Kennedy Trust for Rheumatology Research has had no luck extending a patent license for the blockbuster anti-inflammatory drug Humira. The losing streak continued when a federal appeals court sided with Humira manufacturer AbbVie Inc. and its lawyers at Latham & Watkins and found another of the trust's patents invalid.
      share view
    • 30 January 2015
      Law360
      The firm’s “stable of veteran IP trial attorneys” honored for high-profile patent case wins and strengths across the practice.
      share view
 
 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.